Differential Myolysis of Myocardium and Skeletal Muscle in Hamsters With Dilated Cardiomyopathy Beneficial Protective Effect of Diltiazem

This publication has 19 references indexed in Scilit:

• Repeated Sauna Therapy Increases Arterial Endothelial Nitric Oxide Synthase Expression and Nitric Oxide Production in Cardiomyopathic Hamsters
  Circulation Journal, 2005
• Growth hormone-releasing peptide can improve left ventricular dysfunction and attenuate dilation in dilated cardiomyopathic hamsters
  Cardiovascular Research, 2004
• Serial Alterations of .BETA.-Adrenergic Signaling in Dilated Cardiomyopathic Hamsters-Possible Role of Myocardial Oxidative Stress-
  Circulation Journal, 2004
• VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts
  Cardiovascular Research, 2003
• Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy
  Journal of Clinical Investigation, 2000
• Molecular Pathogenesis of Muscle Degeneration in the δ-Sarcoglycan-Deficient Hamster
  The American Journal of Pathology, 1998
• Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, δ-sarcoglycan, in hamster: An animal model of disrupted dystrophin-associated glycoprotein complex
  Proceedings of the National Academy of Sciences, 1997
• Autosomal recessive limbgirdle muscular dystrophy, LGMD2F, is caused by a mutation in the δ–sarcoglycan gene
  Nature Genetics, 1996
• The causes of dilated cardiomyopathy: A clinicopathologic review of 673 consecutive patients
  Journal of the American College of Cardiology, 1994
• Microvascular spasm in the cardiomyopathic Syrian hamster: a preventable cause of focal myocardial necrosis.
  Circulation, 1982